BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 29345394)

  • 1. Viruses as key modulators of the TGF-β pathway; a double-edged sword involved in cancer.
    Mirzaei H; Faghihloo E
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29345394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The AP-1 pathway; A key regulator of cellular transformation modulated by oncogenic viruses.
    Mirzaei H; Khodadad N; Karami C; Pirmoradi R; Khanizadeh S
    Rev Med Virol; 2020 Jan; 30(1):e2088. PubMed ID: 31788897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β Signaling in Cancer.
    Syed V
    J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor-Beta and Urokinase Type Plasminogen Interplay in Cancer.
    Santibanez JF; Krstic J
    Curr Protein Pept Sci; 2018; 19(12):1155-1163. PubMed ID: 29086689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.
    Liu S; Nheu T; Luwor R; Nicholson SE; Zhu HJ
    J Biol Chem; 2015 Jul; 290(29):17894-17908. PubMed ID: 26032413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β: an emerging player in drug resistance.
    Brunen D; Willems SM; Kellner U; Midgley R; Simon I; Bernards R
    Cell Cycle; 2013 Sep; 12(18):2960-8. PubMed ID: 23974105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
    Ahmadi A; Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Aug; 234(8):12173-12187. PubMed ID: 30537043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β signaling pathway: A promising therapeutic target for cancer.
    Chen Y; Di C; Zhang X; Wang J; Wang F; Yan JF; Xu C; Zhang J; Zhang Q; Li H; Yang H; Zhang H
    J Cell Physiol; 2020 Mar; 235(3):1903-1914. PubMed ID: 31332789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
    Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
    Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
    Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
    J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta signaling in cancer--a double-edged sword.
    Akhurst RJ; Derynck R
    Trends Cell Biol; 2001 Nov; 11(11):S44-51. PubMed ID: 11684442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylases in virus-associated cancers.
    Mirzaei H; Ghorbani S; Khanizadeh S; Namdari H; Faghihloo E; Akbari A
    Rev Med Virol; 2020 Jan; 30(1):e2085. PubMed ID: 31743548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β signaling in cancer.
    Gu S; Feng XH
    Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):941-949. PubMed ID: 30165534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta signaling in cancer invasion and metastasis.
    Leivonen SK; Kähäri VM
    Int J Cancer; 2007 Nov; 121(10):2119-24. PubMed ID: 17849476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
    Yuki R
    Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative modeling and analysis of the transforming growth factor beta signaling pathway.
    Chung SW; Miles FL; Sikes RA; Cooper CR; Farach-Carson MC; Ogunnaike BA
    Biophys J; 2009 Mar; 96(5):1733-50. PubMed ID: 19254534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD7: a timer of tumor progression targeting TGF-β signaling.
    Luo L; Li N; Lv N; Huang D
    Tumour Biol; 2014 Sep; 35(9):8379-85. PubMed ID: 24935472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
    Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
    Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Distinct Roles of Transcriptional Factor KLF11 in Normal Cell Growth Regulation and Cancer as a Mediator of TGF-β Signaling Pathway.
    Lin L; Mahner S; Jeschke U; Hester A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
    Hao Y; Baker D; Ten Dijke P
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.